Palatin Technologies Inc is a biopharmaceutical company engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical need and commercial potential.
Stock Price Prediction
Update at 5:00pm EST
0.832 - 0.837
0.837 - 0.841
0.796 - 0.802
0.802 - 0.808
0.81 - 0.82
0.82 - 0.828
as of: 2019-10-14 4:48:30 PM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.PTN has closed above bottom band by 8.7%. Bollinger Bands are 51.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to PTN's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.